SkinHealth Systems (SKIN)
SkinHealth Systems on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as surgical & medical instruments & apparatus.
376K
Short interest
settlement 2026-10-15
14.3
Days to cover
-7.5 days vs prior
49.5%
Short share of volume
2026-11-02
93,943
Fails to deliver
settlement 2026-10-13
Thu 5 Nov
Next earnings
estimated date
$0
Insider flow, 90 days
0 buys, 0 sells
As of 2026-11-02.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 15 October 2026, short interest in SKIN is 375,655 shares, down 6,806,866 shares over the last month. Over the last 48 readings it ranged from 375,655 shares (15 October 2026) to 17,379,703 shares (14 November 2025). The latest reading sits at the bottom of that range. At the reported average volume of 26K shares a day that is 14.3 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/skin" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-10-15 | 375,655 | -94.8% | 26,346 | 14.26 |
| 2026-09-30 | 7,247,126 | +0.9% | 333,098 | 21.76 |
| 2026-09-15 | 7,182,521 | -0.3% | 295,763 | 24.28 |
| 2026-08-31 | 7,200,336 | +1.8% | 412,811 | 17.44 |
| 2026-08-14 | 7,070,464 | -6.9% | 419,851 | 16.84 |
| 2026-07-31 | 7,594,583 | -13.3% | 822,301 | 9.24 |
| 2026-07-15 | 8,754,624 | -10.2% | 10,332,916 | 1.00 |
| 2026-06-30 | 9,744,464 | -21.8% | 2,074,352 | 4.70 |
| 2026-06-15 | 12,456,415 | -11.4% | 630,197 | 19.77 |
| 2026-05-29 | 14,058,786 | -13.5% | 1,517,877 | 9.26 |
| 2026-05-15 | 16,249,963 | -1.7% | 1,668,917 | 9.74 |
| 2026-04-30 | 16,529,329 | +5.6% | 715,798 | 23.09 |
| 2026-04-15 | 15,653,383 | +1.9% | 515,035 | 30.39 |
| 2026-03-31 | 15,355,687 | +0.1% | 672,182 | 22.84 |
| 2026-03-13 | 15,341,179 | -2.0% | 988,889 | 15.51 |
| 2026-02-27 | 15,651,483 | -0.4% | 723,450 | 21.63 |
| 2026-02-13 | 15,715,026 | -2.1% | 693,260 | 22.67 |
| 2026-01-30 | 16,045,337 | -3.8% | 389,163 | 41.23 |
| 2026-01-15 | 16,677,557 | -0.0% | 334,392 | 49.87 |
| 2025-12-31 | 16,683,970 | -0.7% | 426,656 | 39.10 |
| 2025-12-15 | 16,804,039 | -1.8% | 905,767 | 18.55 |
| 2025-11-28 | 17,108,634 | -1.6% | 616,169 | 27.77 |
| 2025-11-14 | 17,379,703 | +1.6% | 1,391,000 | 12.49 |
| 2025-10-31 | 17,111,032 | -0.6% | 1,180,745 | 14.49 |
| 2025-10-15 | 17,205,031 | -1.0% | 876,463 | 19.63 |
| 2025-09-30 | 17,378,422 | +4.3% | 865,061 | 20.09 |
| 2025-09-15 | 16,667,672 | +6.9% | 1,292,347 | 12.90 |
| 2025-08-29 | 15,591,570 | +0.8% | 570,204 | 27.34 |
| 2025-08-15 | 15,469,500 | +23.4% | 2,108,649 | 7.34 |
| 2025-07-31 | 12,538,505 | +1.4% | 663,260 | 18.90 |
| 2025-07-15 | 12,360,376 | +6.4% | 886,229 | 13.95 |
| 2025-06-30 | 11,618,289 | +24.5% | 1,350,260 | 8.60 |
| 2025-06-13 | 9,335,044 | +11.5% | 570,244 | 16.37 |
| 2025-05-30 | 8,371,322 | +4.0% | 617,887 | 13.55 |
| 2025-05-15 | 8,053,219 | +2.6% | 1,664,338 | 4.84 |
| 2025-04-30 | 7,852,443 | +0.9% | 393,591 | 19.95 |
| 2025-04-15 | 7,784,443 | -6.8% | 897,172 | 8.68 |
| 2025-03-31 | 8,355,445 | -2.6% | 485,900 | 17.20 |
| 2025-03-14 | 8,580,644 | -3.0% | 1,043,439 | 8.22 |
| 2025-02-28 | 8,847,499 | +2.9% | 483,167 | 18.31 |
| 2025-02-14 | 8,598,354 | -2.8% | 428,186 | 20.08 |
| 2025-01-31 | 8,844,186 | +1.3% | 374,972 | 23.59 |
| 2025-01-15 | 8,730,276 | +6.4% | 696,059 | 12.54 |
| 2024-12-31 | 8,201,820 | +7.6% | 590,599 | 13.89 |
| 2024-12-13 | 7,624,169 | -6.8% | 524,372 | 14.54 |
| 2024-11-29 | 8,180,957 | +8.2% | 643,684 | 12.71 |
| 2024-11-15 | 7,558,246 | -11.2% | 1,225,294 | 6.17 |
| 2024-10-31 | 8,510,796 | -12.2% | 634,368 | 13.42 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 2 November 2026, the short share of SKIN volume is 49.5%, down 17.6 points over the last five sessions. Over the last 30 readings it ranged from 20.7% (25 September 2026) to 92.2% (12 October 2026). The latest reading is 2.2 points below the 30-session average of 51.7%, on 12K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-11-02 | 6K | 12K | 49.5% | 0 |
| 2026-10-30 | 22K | 25K | 87.5% | 0 |
| 2026-10-29 | 13K | 19K | 66.3% | 2,965 |
| 2026-10-28 | 3K | 15K | 21.0% | 173 |
| 2026-10-27 | 6K | 13K | 43.9% | 0 |
| 2026-10-26 | 17K | 26K | 67.1% | 3,274 |
| 2026-10-23 | 4K | 17K | 23.0% | 2,556 |
| 2026-10-22 | 9K | 11K | 79.7% | 5,404 |
| 2026-10-21 | 14K | 18K | 75.6% | 3,581 |
| 2026-10-20 | 8K | 13K | 66.7% | 2,748 |
| 2026-10-19 | 22K | 30K | 72.8% | 3,957 |
| 2026-10-16 | 20K | 48K | 41.5% | 6,026 |
| 2026-10-15 | 12K | 21K | 57.1% | 4,506 |
| 2026-10-14 | 17K | 28K | 62.3% | 1,461 |
| 2026-10-13 | 185K | 357K | 51.9% | 27,476 |
| 2026-10-12 | 322K | 349K | 92.2% | 61,554 |
| 2026-10-09 | 196K | 301K | 65.2% | 87,765 |
| 2026-10-08 | 98K | 190K | 51.8% | 0 |
| 2026-10-07 | 18K | 78K | 23.2% | 0 |
| 2026-10-06 | 161K | 227K | 70.7% | 0 |
| 2026-10-05 | 61K | 138K | 44.1% | 9,236 |
| 2026-10-02 | 19K | 65K | 29.5% | 3,224 |
| 2026-10-01 | 78K | 147K | 52.7% | 6,834 |
| 2026-09-30 | 30K | 61K | 49.9% | 12,035 |
| 2026-09-29 | 68K | 121K | 56.2% | 6,738 |
| 2026-09-28 | 37K | 135K | 27.3% | 5,092 |
| 2026-09-25 | 21K | 104K | 20.7% | 0 |
| 2026-09-24 | 28K | 123K | 22.7% | 0 |
| 2026-09-23 | 42K | 133K | 31.8% | 0 |
| 2026-09-22 | 55K | 119K | 46.1% | 0 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 13 October 2026, the fails-to-deliver balance in SKIN is 93,943 shares, up 17,127 shares over the last settlement date. Over the last 30 readings it ranged from 57 shares (18 September 2026) to 93,943 shares (13 October 2026). The latest reading sits at the top of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-10-13 | 93,943 | $0.53 | $50K |
| 2026-10-06 | 76,816 | $0.60 | $46K |
| 2026-10-05 | 65,390 | $0.63 | $41K |
| 2026-10-02 | 49,918 | $0.63 | $31K |
| 2026-10-01 | 32,409 | $0.63 | $20K |
| 2026-09-30 | 15,851 | $0.62 | $10K |
| 2026-09-24 | 1,145 | $0.68 | $779 |
| 2026-09-23 | 104 | $0.67 | $70 |
| 2026-09-21 | 6,737 | $0.68 | $5K |
| 2026-09-18 | 57 | $0.68 | $39 |
| 2026-09-11 | 14,295 | $0.69 | $10K |
| 2026-09-04 | 112 | $0.70 | $78 |
| 2026-08-28 | 224 | $0.69 | $155 |
| 2026-08-27 | 26,713 | $0.69 | $18K |
| 2026-08-26 | 12,682 | $0.65 | $8K |
| 2026-08-25 | 7,219 | $0.68 | $5K |
| 2026-08-24 | 19,707 | $0.65 | $13K |
| 2026-08-21 | 19,707 | $0.63 | $12K |
| 2026-08-20 | 19,707 | $0.59 | $12K |
| 2026-08-19 | 19,707 | $0.60 | $12K |
| 2026-08-18 | 19,707 | $0.60 | $12K |
| 2026-08-17 | 19,707 | $0.67 | $13K |
| 2026-08-14 | 19,707 | $0.66 | $13K |
| 2026-08-13 | 19,707 | $0.65 | $13K |
| 2026-08-12 | 21,547 | $0.70 | $15K |
| 2026-08-11 | 19,707 | $0.64 | $13K |
| 2026-08-10 | 19,707 | $0.66 | $13K |
| 2026-08-07 | 19,707 | $0.77 | $15K |
| 2026-08-06 | 19,707 | $0.71 | $14K |
| 2026-08-05 | 19,707 | $0.71 | $14K |
Insider trades
SEC Form 4, newest first. JSONNo open-market insider trades were reported for SKIN in the last 90 days. The most recent filings are listed below. Latest filing: Malha Pedro Bruno Ferreira (President and CEO) on 2026-10-09.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-10-09 | Malha Pedro Bruno Ferreira | President and CEO | Tax withholding | 78K | $0.55 | $43K | 4.7M |
| 2026-10-09 | Malha Pedro Bruno Ferreira | President and CEO | Tax withholding | 100K | $0.55 | $55K | 4.7M |
| 2026-08-10 | MONAHAN MICHAEL P. | Chief Financial Officer | Tax withholding | 32K | $0.64 | $21K | 2.0M |
| 2026-04-09 | Lewis Sheri | CSO and COO | Tax withholding | 25K | $0.92 | $23K | 1.6M |
| 2026-04-09 | MONAHAN MICHAEL P. | Chief Financial Officer | Tax withholding | 27K | $0.92 | $25K | 2.0M |
| 2026-03-20 | Lewis Sheri | CSO and COO | Grant | 747K | price not stated in the filing | not stated | 1.6M |
| 2026-03-20 | Menezes Ronald | Chief Revenue Officer | Grant | 747K | price not stated in the filing | not stated | 1.8M |
| 2026-03-20 | MONAHAN MICHAEL P. | Chief Financial Officer | Grant | 747K | price not stated in the filing | not stated | 2.0M |
| 2026-03-20 | Malha Pedro Bruno Ferreira | President and CEO | Grant | 2.7M | price not stated in the filing | not stated | 4.8M |
| 2026-03-17 | Lewis Sheri | CSO and COO | Tax withholding | 52K | $1.17 | $61K | 863K |
| 2026-03-17 | Menezes Ronald | Chief Revenue Officer | Tax withholding | 61K | $1.17 | $72K | 1.0M |
| 2026-03-17 | MONAHAN MICHAEL P. | Chief Financial Officer | Tax withholding | 59K | $1.17 | $69K | 1.3M |
| 2025-11-13 | SCHAISON PHILIPPE | Director | Grant | 58K | price not stated in the filing | not stated | 58K |
| 2025-11-01 | Menezes Ronald | Chief Revenue Officer | Tax withholding | 46K | $1.43 | $66K | 1.1M |
| 2025-10-09 | Malha Pedro Bruno Ferreira | President and CEO | Grant | 962K | $1.56 | $1.5M | 2.2M |
| 2025-10-09 | Malha Pedro Bruno Ferreira | President and CEO | Grant | 1.2M | $1.56 | $1.9M | 1.2M |
| 2025-08-10 | MONAHAN MICHAEL P. | Chief Financial Officer | Tax withholding | 32K | $1.89 | $61K | 1.3M |
| 2025-06-16 | FANNING STEPHEN J | Director | Grant | 73K | price not stated in the filing | not stated | 527K |
| 2025-06-16 | Schillinger Doug K. | Director | Grant | 73K | price not stated in the filing | not stated | 216K |
| 2025-06-16 | Miller Brian Christopher | Director | Grant | 73K | price not stated in the filing | not stated | 243K |
| 2025-06-16 | Kerrick Michelle C. | Director | Grant | 73K | price not stated in the filing | not stated | 190K |
| 2025-06-16 | SAUNDERS BRENT L | Director,Other | Grant | 73K | price not stated in the filing | not stated | 6.0M |
| 2025-06-16 | Gruber Desiree | Director | Grant | 73K | price not stated in the filing | not stated | 193K |
| 2025-06-01 | MONAHAN MICHAEL P. | Chief Financial Officer | Tax withholding | 24K | $1.63 | $40K | 1.4M |
| 2025-04-09 | MONAHAN MICHAEL P. | Chief Financial Officer | Tax withholding | 27K | $1.08 | $29K | 1.4M |
| 2025-04-09 | BECK MARLA MALCOLM | President and CEO | Tax withholding | 93K | $1.08 | $100K | 2.8M |
| 2025-04-09 | Lewis Sheri | CSO and COO | Tax withholding | 31K | $1.08 | $34K | 915K |
| 2025-03-17 | MONAHAN MICHAEL P. | Chief Financial Officer | Grant | 639K | $1.32 | $844K | 1.4M |
| 2025-03-17 | BECK MARLA MALCOLM | President and CEO | Grant | 1.8M | $1.32 | $2.4M | 2.8M |
| 2025-03-17 | Menezes Ronald | Chief Revenue Officer | Grant | 639K | $1.32 | $844K | 1.1M |
| 2025-03-17 | Lewis Sheri | CSO and COO | Grant | 639K | $1.32 | $844K | 946K |
| 2024-12-01 | MONAHAN MICHAEL P. | Chief Financial Officer | Tax withholding | 24K | $1.48 | $36K | 771K |
| 2024-11-20 | Gruber Desiree | Director | Sell | 15K | $1.50 | $22K | 120K |
| 2024-08-12 | SAUNDERS BRENT L | Director,Other | Buy | 40K | $1.08 | $44K | 5.9M |
| 2024-08-10 | MONAHAN MICHAEL P. | Chief Financial Officer | Tax withholding | 32K | $1.12 | $36K | 795K |
| 2024-07-08 | SAUNDERS BRENT L | Director,Other | Grant | 79K | price not stated in the filing | not stated | 5.9M |
| 2024-07-08 | CAPELLAS MICHAEL D | Director | Grant | 79K | price not stated in the filing | not stated | 276K |
| 2024-07-08 | Few Julius | Director | Grant | 79K | price not stated in the filing | not stated | 194K |
| 2024-07-08 | Kerrick Michelle C. | Director | Grant | 79K | price not stated in the filing | not stated | 117K |
| 2024-07-08 | Schillinger Doug K. | Director | Grant | 79K | price not stated in the filing | not stated | 143K |
| 2024-07-08 | Miller Brian Christopher | Director | Grant | 79K | price not stated in the filing | not stated | 170K |
| 2024-07-08 | Gruber Desiree | Director | Grant | 79K | price not stated in the filing | not stated | 134K |
| 2024-04-09 | BECK MARLA MALCOLM | President and CEO | Grant | 838K | price not stated in the filing | not stated | 1.1M |
| 2024-04-09 | MONAHAN MICHAEL P. | Chief Financial Officer | Grant | 292K | price not stated in the filing | not stated | 827K |
| 2024-04-09 | Watson Daniel Copell | Chief Revenue Oficer | Grant | 244K | price not stated in the filing | not stated | 809K |
| 2024-04-08 | BECK MARLA MALCOLM | President and CEO | Tax withholding | 21K | $3.80 | $81K | 1.0M |
| 2024-04-05 | Watson Daniel Copell | Chief Revenue Oficer | Tax withholding | 11K | $3.71 | $42K | 778K |
| 2024-03-20 | BECK MARLA MALCOLM | President and CEO | Tax withholding | 11K | $4.36 | $47K | 1.0M |
| 2024-03-01 | Watson Daniel Copell | Chief Revenue Oficer | Tax withholding | 6K | $3.73 | $24K | 789K |
| 2024-02-20 | BECK MARLA MALCOLM | President and CEO | Tax withholding | 11K | $2.98 | $32K | 1.0M |
| 2024-02-04 | Watson Daniel Copell | Chief Revenue Oficer | Tax withholding | 11K | $2.98 | $32K | 796K |
| 2024-01-20 | BECK MARLA MALCOLM | President and CEO | Tax withholding | 11K | $2.43 | $26K | 1.1M |
| 2023-12-20 | BECK MARLA MALCOLM | President and CEO | Tax withholding | 11K | $3.18 | $34K | 1.1M |
| 2023-11-29 | MONAHAN MICHAEL P. | Chief Financial Officer | Grant | 177K | price not stated in the filing | not stated | 535K |
| 2023-11-29 | Hauser Bradley | Chief Operating Officer | Grant | 177K | price not stated in the filing | not stated | 391K |
| 2023-11-29 | Watson Daniel Copell | Chief Revenue Oficer | Grant | 156K | price not stated in the filing | not stated | 565K |
| 2023-11-20 | BECK MARLA MALCOLM | Interim CEO | Grant | 214K | price not stated in the filing | not stated | 241K |
| 2023-08-17 | Stanleick Andrew Roy | Chief Executive Officer | Buy | 16K | $6.05 | $100K | 703K |
| 2023-08-17 | MONAHAN MICHAEL P. | Chief Financial Officer | Buy | 5K | $6.02 | $30K | 358K |
| 2023-08-17 | CAPELLAS MICHAEL D | Director | Buy | 30K | $6.03 | $181K | 198K |
| 2023-08-17 | Miller Brian Christopher | Director | Buy | 60K | $5.81 | $349K | 91K |
| 2023-08-16 | SAUNDERS BRENT L | Director,Other | Buy | 59K | $6.10 | $362K | 5.8M |
| 2023-08-16 | Schillinger Doug K. | Director | Buy | 33K | $6.11 | $202K | 64K |
| 2023-08-16 | Few Julius | Director | Buy | 20K | $6.10 | $125K | 116K |
| 2023-08-10 | MONAHAN MICHAEL P. | Chief Financial Officer | Grant | 353K | price not stated in the filing | not stated | 353K |
| 2023-07-07 | Miller Brian Christopher | TenPercentOwner | Other transaction | 3.2M | $0.00 | $0 | 33.4M |
| 2023-07-07 | Kerrick Michelle C. | Director | Other transaction | 7K | price not stated in the filing | not stated | 38K |
| 2023-07-07 | Kerrick Michelle C. | Director | Other transaction | 7K | price not stated in the filing | not stated | 38K |
| 2023-06-14 | SAUNDERS BRENT L | Director,Other | Grant | 16K | price not stated in the filing | not stated | 5.8M |
| 2023-06-14 | Gruber Desiree | Director | Grant | 16K | price not stated in the filing | not stated | 56K |
| 2023-06-14 | Miller Brian Christopher | Director | Grant | 16K | price not stated in the filing | not stated | 31K |
| 2023-06-14 | CAPELLAS MICHAEL D | Director | Grant | 16K | price not stated in the filing | not stated | 31K |
| 2023-06-14 | Schillinger Doug K. | Director | Grant | 16K | price not stated in the filing | not stated | 31K |
| 2023-06-14 | Few Julius | Director | Grant | 16K | price not stated in the filing | not stated | 31K |
| 2023-06-14 | BECK MARLA MALCOLM | Director | Grant | 16K | price not stated in the filing | not stated | 27K |
| 2023-06-14 | Kerrick Michelle C. | Director | Grant | 16K | price not stated in the filing | not stated | 31K |
| 2023-04-19 | Hauser Bradley | Chief Operating Officer | Grant | 77K | price not stated in the filing | not stated | 214K |
| 2023-04-05 | Woo Liyuan | Chief Financial Officer | Grant | 118K | price not stated in the filing | not stated | 591K |
| 2023-04-05 | Watson Daniel Copell | Chief Revenue Oficer | Grant | 94K | price not stated in the filing | not stated | 409K |
| 2023-04-05 | Stanleick Andrew Roy | Chief Executive Officer | Grant | 295K | price not stated in the filing | not stated | 686K |
| 2023-03-01 | Woo Liyuan | Chief Financial Officer | Grant | 19K | price not stated in the filing | not stated | 474K |
| 2023-03-01 | Watson Daniel Copell | Chief Revenue Oficer | Grant | 18K | price not stated in the filing | not stated | 315K |
| 2023-03-01 | Stanleick Andrew Roy | Chief Executive Officer | Grant | 59K | price not stated in the filing | not stated | 392K |
| 2023-02-04 | Watson Daniel Copell | Chief Revenue Oficer | Tax withholding | 9K | $12.90 | $116K | 806K |
| 2023-02-03 | SAUNDERS BRENT L | Director,Other | Tax withholding | 14K | $12.90 | $175K | 5.8M |
| 2022-12-30 | SAUNDERS BRENT L | Director,Other | Tax withholding | 2K | $9.10 | $20K | 5.8M |
| 2022-09-30 | SAUNDERS BRENT L | Director,Other | Tax withholding | 2K | $11.79 | $26K | 5.8M |
| 2022-06-30 | SAUNDERS BRENT L | Director,Other | Tax withholding | 3K | $12.86 | $40K | 5.8M |
| 2022-06-28 | CAPELLAS MICHAEL D | Director | Grant | 10K | price not stated in the filing | not stated | 15K |
| 2022-06-28 | Schillinger Doug K. | Director | Grant | 10K | price not stated in the filing | not stated | 15K |
| 2022-06-28 | BECK MARLA MALCOLM | Director | Grant | 10K | price not stated in the filing | not stated | 11K |
| 2022-06-28 | Kerrick Michelle C. | Director | Grant | 10K | price not stated in the filing | not stated | 15K |
| 2022-06-28 | Miller Brian Christopher | Director | Grant | 10K | price not stated in the filing | not stated | 15K |
| 2022-06-28 | Gruber Desiree | Director | Grant | 10K | price not stated in the filing | not stated | 39K |
| 2022-06-28 | Few Julius | Director | Grant | 10K | price not stated in the filing | not stated | 15K |
| 2022-06-06 | BECK MARLA MALCOLM | Director | Grant | 587 | price not stated in the filing | not stated | 587 |
| 2022-03-31 | SAUNDERS BRENT L | Director,Other | Tax withholding | 4K | $16.88 | $63K | 5.8M |
| 2022-02-07 | Stanleick Andrew Roy | Chief Executive Officer | Grant | 333K | price not stated in the filing | not stated | 333K |
| 2022-02-04 | Watson Daniel Copell | Executive VP Americas Sales | Grant | 78K | price not stated in the filing | not stated | 295K |
| 2022-02-04 | Pamamull Indra | President, APAC | Grant | 67K | price not stated in the filing | not stated | 67K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON2 Form 144 notices on file for SKIN worth $123K at the prices reported; 0 in the last 90 days worth $0. Latest: Menezes Ronald filed on 2026-05-20 to sell 165,000 shares ($115K) from 2026-05-20.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-05-20 | Menezes RonaldFormer Officer | 165K | $115K | 0.127% | 2026-05-20 | Fidelity Brokerage Services LLC |
| 2025-12-05 | BECK MARLA MALCOLMFormer Officer & Director | 5K | $8K | 0.004% | 2025-12-05 | Fidelity Brokerage Services LLC |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON15 holders report 5% or more of SKIN in their latest filing, 7 on Schedule 13D (active intent). The largest reported stake is Brian Miller at 25.7% of the class (33,360,741 shares), filed 2026-05-11 for an event on 2026-05-07.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-07-27 | 13G/Ano. 1 | BlackRock, Inc.parent holding company | 1.3M | 1.0% | 2026-06-30 |
| 2026-07-17 | 13G | BlackRock Portfolio Management LLCparent holding company | 7.2M | 5.6% | 2026-06-30 |
| 2026-07-13 | 13G/Ano. 1 | Capricorn Fund Managers Ltdinvestment adviser | 22.3M | 17.2% | 2026-05-15 |
| 2026-07-08 | 13G/Ano. 9 | Abigail P. Johnsonindividual | 10.2M | 7.9% | 2026-06-30 |
| 2026-07-08 | 13G/Ano. 9 | FMR LLCparent holding company | 10.2M | 7.9% | 2026-06-30 |
| 2026-05-11 | 13D/Ano. 5 | Brian Millerindividual | 33.4M | 25.7% | 2026-05-07 |
| 2026-05-11 | 13D/Ano. 5 | Anthony Davisindividual | 33.4M | 25.7% | 2026-05-07 |
| 2026-05-11 | 13D/Ano. 5 | Linden Capital Partners III-A LPpartnership | 33.4M | 25.7% | 2026-05-07 |
| 2026-05-11 | 13D/Ano. 5 | Linden Capital Partners III LPpartnership | 33.4M | 25.7% | 2026-05-07 |
| 2026-05-11 | 13D/Ano. 5 | Linden Manager III LPpartnership | 33.4M | 25.7% | 2026-05-07 |
| 2026-05-11 | 13D/Ano. 5 | Linden Capital III LLCother entity | 33.4M | 25.7% | 2026-05-07 |
| 2026-05-11 | 13D/Ano. 5 | LCP Edge Holdco, LLCother entity | 33.4M | 25.7% | 2026-05-07 |
| 2026-04-20 | 13G | Israel A. Englanderindividual | 6.5M | 5.1% | 2026-04-14 |
| 2026-04-20 | 13G | Millennium Group Management LLCother entity | 6.5M | 5.1% | 2026-04-14 |
| 2026-04-20 | 13G | Millennium Management LLCother entity | 6.5M | 5.1% | 2026-04-14 |
| 2026-04-20 | 13G | Integrated Core Strategies (US) LLCother entity | 6.5M | 5.1% | 2026-04-14 |
| 2026-02-06 | 13G/Ano. 2 | Mirabella Financial Services LLPinvestment adviser | 0 | 0.0% | 2026-01-31 |
13F holders
Tracked managers holding SKIN at their latest 13F. JSON6 of the 30 tracked managers held SKIN at their latest 13F, $6.9M in total at quarter-end prices. Millennium Management is the largest at $5.2M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 4 added shares and 2 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Millennium Management | 2026-06-30 | 7.5M | $5.2M | 0.00% | +1.8M |
| D. E. Shaw & Co. | 2026-06-30 | 1.4M | $992K | 0.00% | -466K |
| AQR Capital Management | 2026-06-30 | 484K | $335K | 0.00% | -16K |
| Renaissance Technologies | 2026-06-30 | 365K | $253K | 0.00% | +81K |
| Citadel Advisors | 2026-06-30 | 170K | $118K | 0.00% | +127K |
| Point72 Asset Management | 2026-06-30 | 47K | $32K | 0.00% | new |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
What this page is
SkinHealth Systems in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows SkinHealth Systems (SKIN), SEC CIK 1818093, listed on Nasdaq, classified by the SEC as surgical & medical instruments & apparatus. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-02.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-13.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-05-20.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-07-27.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-06.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-10-09.JSON and CSV
- Company record
- EDGAR filing index for CIK 1818093Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as surgical & medical instruments & apparatus
Other company pages
- STESTERIS
- STLDSteel Dynamics
- STRCStrategy
- STRLSterling Infrastructure
- STTState Street
- STXSeagate Technology Holdings
- STZConstellation Brands
- SUISun Communities
- SUNBSunbelt Rentals Holdings
- SWSmurfit Westrock
- SWKStanley Black & Decker
- SWKSSkyworks Solutions
- SXTCChina SXT Pharmaceuticals
- SYFSynchrony Financial
- SYKStryker
- SYNASynaptics
Datasets
Frequently Asked Questions
How much of SKIN is sold short?
375,655 shares were held short at the 2026-10-15 settlement, 14.3 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is SKIN's daily short volume?
On 2026-11-02, 5,928 of the 11,989 SKIN shares reported to FINRA were sold short, 49.5% of the day's reported volume. Short volume is a flow for one day, not a position.
Does SKIN have fails to deliver?
The SEC's latest file shows 93,943 SKIN shares failed to deliver at settlement 2026-10-13. Fails are reported per settlement date and published twice a month with a lag.
Are SKIN insiders buying or selling?
No open-market insider trades were reported for SKIN in the last 90 days. The most recent filings are listed below. Latest filing: Malha Pedro Bruno Ferreira (President and CEO) on 2026-10-09.
Have SKIN insiders filed to sell?
2 Form 144 notices on file for SKIN worth $123K at the prices reported; 0 in the last 90 days worth $0. Latest: Menezes Ronald filed on 2026-05-20 to sell 165,000 shares ($115K) from 2026-05-20.
Who owns 5% or more of SKIN?
15 holders report 5% or more of SKIN in their latest filing, 7 on Schedule 13D (active intent). The largest reported stake is Brian Miller at 25.7% of the class (33,360,741 shares), filed 2026-05-11 for an event on 2026-05-07.
Which tracked 13F managers own SKIN?
6 of the 30 tracked 13F managers held SKIN shares at their latest filing, $6.9M in all. The largest: Izzy Englander's Millennium Management (7.5M shares, $5.2M), D. E. Shaw & Co. (1.4M shares, $992K), Cliff Asness's AQR Capital Management (484K shares, $335K), Renaissance Technologies (365K shares, $253K), Ken Griffin's Citadel Advisors (170K shares, $118K), Steve Cohen's Point72 Asset Management (47K shares, $32K).
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.